About ELIGARD

ELIGARD is a prescription medication containing the active ingredient Leuprolide Acetate, a synthetic nonapeptide analogue of naturally occurring luteinizing hormone-releasing hormone (LHRH). It is used to treat conditions associated with an overproduction of sex hormones, such as prostate cancer and endometriosis.

Key Benefits & Uses

Treatment of prostate cancer, including metastatic hormone-refractory prostate cancer
Control of symptoms associated with endometriosis, including pelvic pain and heavy menstrual bleeding
Prevention of estrogen receptor-positive breast cancer recurrence

Active Ingredient & Action

Leuprolide Acetate works by mimicking the action of LHRH, a hormone produced by the hypothalamus that regulates the production of sex hormones. By binding to LHRH receptors in the pituitary gland, Leuprolide Acetate suppresses the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a decrease in sex hormone production. This reduction in sex hormone levels can help alleviate symptoms associated with conditions such as prostate cancer and endometriosis.

Important Notes

ELIGARD is available in a variety of formulations, including a 7.5 mg monthly depot injection. It is essential to follow the recommended dosing schedule and consult with a healthcare professional before starting treatment. Common side effects may include hot flashes, injection site reactions, and changes in libido. Patients with a history of hypersensitivity to Leuprolide Acetate or other LHRH analogues should not use ELIGARD.